IRIS UniCatt

D'Alo', Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.005
EU - Europa 5.145
AS - Asia 4.137
SA - Sud America 632
OC - Oceania 177
AF - Africa 140
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.239
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.751
DE - Germania 1.736
SG - Singapore 1.588
CN - Cina 1.268
IT - Italia 703
SE - Svezia 681
BR - Brasile 505
VN - Vietnam 426
FR - Francia 344
GB - Regno Unito 331
UA - Ucraina 298
PL - Polonia 264
IN - India 204
FI - Finlandia 178
CA - Canada 166
IE - Irlanda 160
AU - Australia 152
ID - Indonesia 115
JP - Giappone 85
TR - Turchia 74
RU - Federazione Russa 73
HK - Hong Kong 68
NL - Olanda 65
MX - Messico 53
AR - Argentina 40
BD - Bangladesh 39
AT - Austria 38
ES - Italia 38
ZA - Sudafrica 34
IQ - Iraq 33
CH - Svizzera 27
BE - Belgio 26
IR - Iran 26
PK - Pakistan 26
RO - Romania 25
KR - Corea 24
CI - Costa d'Avorio 23
NZ - Nuova Zelanda 23
CZ - Repubblica Ceca 19
CO - Colombia 17
EG - Egitto 17
VE - Venezuela 17
GR - Grecia 16
IL - Israele 16
MY - Malesia 16
SA - Arabia Saudita 16
AE - Emirati Arabi Uniti 15
HU - Ungheria 15
DZ - Algeria 14
EC - Ecuador 14
LT - Lituania 12
MA - Marocco 12
PY - Paraguay 12
BG - Bulgaria 11
CL - Cile 11
PT - Portogallo 11
UZ - Uzbekistan 11
KE - Kenya 10
NO - Norvegia 10
PH - Filippine 10
TH - Thailandia 10
DK - Danimarca 9
LB - Libano 9
SK - Slovacchia (Repubblica Slovacca) 9
HR - Croazia 7
JM - Giamaica 7
JO - Giordania 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
GE - Georgia 6
HN - Honduras 6
NP - Nepal 6
PE - Perù 6
RS - Serbia 6
TN - Tunisia 6
AZ - Azerbaigian 5
BA - Bosnia-Erzegovina 5
KG - Kirghizistan 5
LV - Lettonia 5
UY - Uruguay 5
AM - Armenia 4
BO - Bolivia 4
CG - Congo 4
MK - Macedonia 4
OM - Oman 4
SI - Slovenia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
BY - Bielorussia 3
EE - Estonia 3
GH - Ghana 3
LK - Sri Lanka 3
LY - Libia 3
ME - Montenegro 3
PR - Porto Rico 3
PS - Palestinian Territory 3
BB - Barbados 2
CR - Costa Rica 2
Totale 17.210
Salva come PNG Salva come JPEG
Città #
Singapore 936
Chandler 638
Ashburn 574
San Jose 414
Beijing 304
Jacksonville 222
Warsaw 222
Munich 193
Houston 169
Los Angeles 154
Dublin 151
Nanjing 150
Dearborn 142
San Mateo 140
New York 136
Woodbridge 133
Ann Arbor 132
Fairfield 131
Milan 131
Ho Chi Minh City 129
Hanoi 120
Rome 116
Wilmington 113
Hangzhou 105
Nürnberg 95
Jakarta 94
Redwood City 93
Seattle 93
Helsinki 92
Chicago 89
The Dalles 86
Lauterbourg 83
Cambridge 76
Dallas 76
Tokyo 69
Bremen 67
Hefei 67
Hong Kong 63
Nanchang 59
Boston 58
Frankfurt am Main 58
Council Bluffs 56
Cattolica 52
Lawrence 52
Moscow 52
Orem 48
São Paulo 48
Buffalo 46
London 40
Izmir 37
Marseille 37
Santa Clara 37
Brooklyn 36
Sydney 36
Guangzhou 35
Kunming 33
Shanghai 33
Portland 31
Lancaster 29
Toronto 29
Haiphong 28
Phoenix 28
San Francisco 27
Boardman 26
Melbourne 25
Montreal 25
Hyderabad 24
Shenyang 24
Abidjan 23
Brisbane 23
Chennai 23
Denver 23
Princeton 23
Adelaide 22
Atlanta 22
Tianjin 22
Brussels 21
Poplar 21
Johannesburg 20
Kent 20
Changsha 19
Leawood 19
Nuremberg 19
Amsterdam 18
Auburn Hills 18
Da Nang 18
Hebei 18
Redmond 18
Fremont 17
Jiaxing 17
Mexico City 17
Philadelphia 17
Mumbai 16
Baghdad 15
Manchester 15
Mountain View 15
San Diego 15
University Park 15
Zhengzhou 15
Augusta 14
Totale 8.545
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 3.258
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 431
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 339
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 328
DNMT1-interacting RNAs block gene-specific DNA methylation 289
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 284
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 278
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 269
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 241
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 240
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 239
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 236
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 233
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 231
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 229
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 221
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 214
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 192
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 191
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 190
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 190
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 188
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 182
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 180
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 180
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 180
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 179
Epigenetic changes in therapy-related MDS/AML 177
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 176
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 175
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 174
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 172
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 170
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 169
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 169
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 168
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 167
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 157
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 157
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine. 154
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 154
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 153
PU.1 and CEBPA expression in acute myeloid leukemia. 153
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 152
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 152
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 152
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 152
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 151
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 150
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 149
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 148
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 147
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 147
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 146
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 143
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 142
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden 141
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 138
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 138
Outcome of therapy-related myeloid neoplasms treated with azacitidine 137
Mantle cell lymphoma relapsing at the lymphedematous arm 137
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 137
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 132
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy 132
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 131
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab 129
Aggiornamenti di Diagnostica Molecolare in Ematologia 126
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma 126
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 125
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 124
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 121
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 118
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 118
Burkitt lymphoma as fourth neoplasia in a patient affected by cowden syndrome with a novel PTEN germline pathogenic variant 118
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 117
CAR-T Cell Therapy for Follicular Lymphomas 104
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 101
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study 99
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing 85
Secondary Orbital and Intraocular Lymphoma Treated With Immunochemotherapy 84
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 80
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 78
The Predictive Role of Baseline 18F-FDG PET/CT Radiomics in Follicular Lymphoma on Watchful Waiting: A Preliminary Study 77
Case of metastatic melanoma in bone marrow smear 76
Absence of structural mutations of the BAK gene in B cell lymphomas 72
Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line 67
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies 37
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 29
Totale 17.422
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.395
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021376 0 0 0 0 0 0 0 0 0 88 247 41
2021/2022871 103 80 13 31 65 36 26 133 51 70 122 141
2022/20231.867 259 261 128 319 114 216 95 141 175 39 74 46
2023/20241.669 54 256 71 92 114 193 81 109 81 151 226 241
2024/20252.804 297 204 269 144 224 113 210 149 325 224 357 288
2025/20264.951 646 223 268 489 892 336 981 364 426 326 0 0
Totale 17.422